Biospecifics Tech Cp (BSTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2008 | 12-2007 | 09-2007 | 06-2007 | 03-2007 | |
| Sales | 401 | 414 | 369 | 370 | 360 |
| Gross Profit | 401 | 414 | 369 | 370 | 360 |
| Operating Expenses | 895 | 2,493 | 1,144 | 885 | 1,484 |
| Operating Income | -494 | -2,079 | -775 | -515 | -1,123 |
| Interest Expense | 1 | 0 | 0 | 0 | 0 |
| Other Income | 30 | -106 | 29 | 37 | 41 |
| Pre-tax Income | -464 | -2,185 | -745 | -478 | -1,082 |
| Income Tax | 0 | 50 | N/A | 0 | 4 |
| Net Income Continuous | -464 | -2,235 | -745 | -478 | -1,086 |
| Net Income | $-464 | $-2,235 | $-745 | $-478 | $-1,086 |
| EPS Basic Total Ops | -0.08 | -0.42 | -0.14 | -0.09 | -0.21 |
| EPS Basic Continuous Ops | -0.08 | -0.42 | -0.14 | -0.09 | -0.21 |
| EPS Diluted Total Ops | -0.08 | -0.42 | -0.14 | -0.09 | -0.21 |
| EPS Diluted Continuous Ops | -0.08 | -0.42 | -0.14 | -0.09 | -0.21 |
| EBITDA(a) | $-486 | $-2,071 | $-767 | $-507 | $-1,115 |